Canada markets closed

Harvard Bioscience, Inc. (HBI.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
2.6200-0.0600 (-2.24%)
At close: 08:52AM CEST
Show:
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
106,787
112,250
113,335
118,904
102,100
Cost of Revenue
44,290
46,179
52,516
51,252
44,059
Gross Profit
62,497
66,071
60,819
67,652
58,041
Operating Expenses
Research Development
11,752
11,764
12,329
10,799
8,685
Selling General and Administrative
46,443
46,888
49,534
48,947
43,425
Total Operating Expenses
64,631
64,177
67,985
65,586
57,820
Operating Income or Loss
-2,134
1,894
-7,166
2,066
221
Interest Expense
3,368
3,591
2,548
1,540
4,831
Total Other Income/Expenses Net
-2,745
-859
535
-666
-2,682
Income Before Tax
-8,247
-2,556
-9,179
-140
-7,292
Income Tax Expense
484
859
337
148
518
Income from Continuing Operations
-8,731
-3,415
-9,516
-288
-7,810
Net Income
-8,731
-3,415
-9,516
-288
-7,810
Net Income available to common shareholders
-8,731
-3,415
-9,516
-288
-7,810
Basic EPS
-0.04
-0.08
-0.23
-0.01
-0.20
Diluted EPS
-0.04
-0.08
-0.23
-0.01
-0.20
Basic Average Shares
39,887
42,420
41,413
40,343
38,640
Diluted Average Shares
39,887
42,420
41,413
40,343
38,640